var data={"title":"Treatment protocols for small-cell carcinoma of the lung","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Treatment protocols for small-cell carcinoma of the lung</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-small-cell-carcinoma-of-the-lung/contributors\" class=\"contributor contributor_credentials\">Tim Brenner, PharmD, BCOP</a></dd><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-small-cell-carcinoma-of-the-lung/contributors\" class=\"contributor contributor_credentials\">Shrina Duggal, PharmD, BCOP</a></dd><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-small-cell-carcinoma-of-the-lung/contributors\" class=\"contributor contributor_credentials\">Jim Natale, PharmD, BCOP</a></dd><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-small-cell-carcinoma-of-the-lung/contributors\" class=\"contributor contributor_credentials\">Scott M Wirth, PharmD, BCOP</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-small-cell-carcinoma-of-the-lung/contributors\" class=\"contributor contributor_credentials\">John W Mucenski, PharmD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-small-cell-carcinoma-of-the-lung/contributors\" class=\"contributor contributor_credentials\">Sadhna R Vora, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-small-cell-carcinoma-of-the-lung/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jan 27, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H6926341\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The following material represents a subset of chemotherapy regimens that are used for the treatment of patients with small-cell carcinoma of the lung. <strong>This is</strong> <strong>not an exhaustive list</strong>; it includes regimens that are considered by the authors and editors to be commonly used and important for the care of patients with small-cell carcinoma of the lung. Additional regimens may be added over time, particularly as treatment for small-cell carcinoma of the lung evolves.</p><p>This topic review is intended to provide only a listing of chemotherapy regimens. It does not address the appropriate context for use of these regimens in the care of patients with small-cell carcinoma of the lung. Clinicians should refer to the individual disease-oriented topic reviews that discuss the use of these protocols in appropriate clinical situations:</p><p><ul class=\"bullet-block\"><li>(See <a href=\"topic.htm?path=extensive-stage-small-cell-lung-cancer-initial-management\" class=\"medical medical_review\">&quot;Extensive stage small cell lung cancer: Initial management&quot;</a>.)</li></ul></p><p>These tables are provided as examples of how to administer these regimens; there may be other acceptable methods. All chemotherapy regimens must be administered by clinicians who are trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.</p><p class=\"headingAnchor\" id=\"H121173046\"><span class=\"h1\">REGIMENS</span></p><p class=\"headingAnchor\" id=\"H936901476\"><span class=\"h2\">Carboplatin plus etoposide</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>(<a href=\"image.htm?imageKey=ONC%2F75586\" class=\"graphic graphic_table graphicRef75586 \">table 1</a>)</p><p class=\"headingAnchor\" id=\"H936901501\"><span class=\"h2\">Cisplatin (60 mg/m2) plus etoposide</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>(<a href=\"image.htm?imageKey=ONC%2F58176\" class=\"graphic graphic_table graphicRef58176 \">table 2</a>)</p><p class=\"headingAnchor\" id=\"H936901526\"><span class=\"h2\">Cisplatin (80 mg/m2) plus etoposide</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>(<a href=\"image.htm?imageKey=ONC%2F66855\" class=\"graphic graphic_table graphicRef66855 \">table 3</a>)</p><p class=\"headingAnchor\" id=\"H6144680\"><span class=\"h2\">Irinotecan plus cisplatin</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>(<a href=\"image.htm?imageKey=ONC%2F81594\" class=\"graphic graphic_table graphicRef81594 \">table 4</a>)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"topicVersionRevision\">Topic 85693 Version 11.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li><a href=\"#H6926341\" id=\"outline-link-H6926341\">INTRODUCTION</a></li><li><a href=\"#H121173046\" id=\"outline-link-H121173046\">REGIMENS</a><ul><li><a href=\"#H936901476\" id=\"outline-link-H936901476\">Carboplatin plus etoposide</a></li><li><a href=\"#H936901501\" id=\"outline-link-H936901501\">Cisplatin (60 mg/m2) plus etoposide</a></li><li><a href=\"#H936901526\" id=\"outline-link-H936901526\">Cisplatin (80 mg/m2) plus etoposide</a></li><li><a href=\"#H6144680\" id=\"outline-link-H6144680\">Irinotecan plus cisplatin</a></li></ul></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ONC/85693|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ONC/75586\" class=\"graphic graphic_table\">- Carboplatin plus etoposide for small cell lung cancer</a></li><li><a href=\"image.htm?imageKey=ONC/58176\" class=\"graphic graphic_table\">- Cisplatin 60 plus etoposide for small cell lung cancer</a></li><li><a href=\"image.htm?imageKey=ONC/66855\" class=\"graphic graphic_table\">- Cisplatin 80 plus etoposide for small cell lung cancer</a></li><li><a href=\"image.htm?imageKey=ONC/81594\" class=\"graphic graphic_table\">- Irinotecan and cisplatin SCLC</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=extensive-stage-small-cell-lung-cancer-initial-management\" class=\"medical medical_review\">Extensive stage small cell lung cancer: Initial management</a></li></ul></div></div>","javascript":null}